Affimed appoints Shawn Leland as chief executive officer
by
Contributor since / Followers
Contributor since / Followers
3 months ago
- Affimed N.V. (NASDAQ:AFMD) has announced that Shawn M. Leland, PharmD, RPh has been appointed as Chief Executive Officer (CEO).
- Dr. Andreas Harstrick, acting CEO since January 2024 will continue in his position as Chief Medical Officer (CMO).
- Most recently, Shawn was the Interim CEO and Board Director of ForeBio.
- Source: Press Release